share_log

HC Wainwright & Co. Maintains Buy on AngioDynamics, Lowers Price Target to $18

HC Wainwright & Co. Maintains Buy on AngioDynamics, Lowers Price Target to $18

HC Wainwright & Co.維持對AngioDynamics的買入,將目標股價下調至18美元
Benzinga ·  01/08 06:33

HC Wainwright & Co. analyst Yi Chen maintains AngioDynamics (NASDAQ:ANGO) with a Buy and lowers the price target from $20 to $18.

HC Wainwright & Co. 分析師陳毅維持AngioDynamics(納斯達克股票代碼:ANGO)的買入並將目標股價從20美元下調至18美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論